Intelgenx Technologies Corp
TSX:IGX
Intelgenx Technologies Corp
Inventory
Intelgenx Technologies Corp
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Intelgenx Technologies Corp
TSX:IGX
|
Inventory
$173k
|
CAGR 3-Years
13%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Inventory
$1.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Inventory
CA$105.6m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
15%
|
|
|
Cronos Group Inc
TSX:CRON
|
Inventory
$48.2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Inventory
CA$144.4m
|
CAGR 3-Years
19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
57%
|
|
Intelgenx Technologies Corp
Glance View
IntelGenx Technologies Corp. is a oral drug delivery company, which focuses on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilm technology platform. The company is headquartered in Saint-Laurent, Quebec. The company went IPO on 2008-05-23. The firm is focused on the development and manufacturing of pharmaceutical films. The firm's pharmaceutical film technologies include VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, which allows pharmaceutical products that address unmet medical needs. The firm's product pipeline offers various benefits to patients and physicians for many therapeutic conditions. Its VersaFilm research and development (R&D) services are based on a versatile drug delivery platform technology that enables the development of oral thin films exhibiting improved product performance. Its VetaFilm R&D services and veterinary oral films provide various market opportunities for improved drug delivery for companion animals. Its product portfolio includes RIZAPORT (Rizatriptan), EXORDIA (Tadalafil), Loxapine, Montelukast, Buprenorphine / Naloxone, and Dronabinol AdVersa (Dronabinol).
See Also
What is Intelgenx Technologies Corp's Inventory?
Inventory
173k
USD
Based on the financial report for Mar 31, 2024, Intelgenx Technologies Corp's Inventory amounts to 173k USD.
What is Intelgenx Technologies Corp's Inventory growth rate?
Inventory CAGR 5Y
-15%
Over the last year, the Inventory growth was 147%. The average annual Inventory growth rates for Intelgenx Technologies Corp have been 13% over the past three years , -15% over the past five years .
